Literature DB >> 7542833

The untreated patient with squamous carcinoma of the head and neck.

A S Jones1.   

Abstract

Of 3,482 patients with head and neck squamous carcinoma, 539 were unsuitable for radical treatment. Patients over 60 years of age were 1.6 times more likely not to receive radical treatment than younger patients. Patients who were unfit [Eastern Cooperative Oncology Group (ECOG) 1-4] were 1.4 times more likely not to receive radical treatment than those who were generally well. Patients with advanced primary tumours (T3, T4) were twice as likely to be considered unsuitable for radical treatment as patients with small tumours. Patients with neck node metastases were 2.1 times more likely to be considered unsuitable for radical treatment compared with those without nodes. In addition, if neck nodes were present their site influenced the decision to treat radically. Patients with disease low in the neck were 1.3 times more likely to be considered unsuitable for radical treatment than those with disease high in the neck. Survival for untreated patients was dismal. The median tumour specific survival was 5 months, and the 5-year survival was 4%. In contrast the 5-year survival for treated patients was 60%. Cox's regression on untreated patients showed that advanced age, poor general condition, and advanced nodal disease all adversely affected survival.

Entities:  

Mesh:

Year:  1995        PMID: 7542833     DOI: 10.1097/00000421-199508000-00018

Source DB:  PubMed          Journal:  Am J Clin Oncol        ISSN: 0277-3732            Impact factor:   2.339


  3 in total

1.  Untreated head and neck cancer in Korea: a national cohort study.

Authors:  Hyo Geun Choi; Bumjung Park; Soon-Hyun Ahn
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-11-14       Impact factor: 2.503

Review 2.  Causes of death of patients with laryngeal cancer.

Authors:  Alfio Ferlito; Missak Haigentz; Patrick J Bradley; Carlos Suárez; Primož Strojan; Gregory T Wolf; Kerry D Olsen; William M Mendenhall; Vanni Mondin; Juan P Rodrigo; Carsten C Boedeker; Marc Hamoir; Dana M Hartl; Jennifer L Hunt; Kenneth O Devaney; Lester D R Thompson; Alessandra Rinaldo; Robert P Takes
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-04-17       Impact factor: 2.503

3.  Local Tumor Control and Normal Tissue Toxicity of Pulsed Low-Dose Rate Radiotherapy for Recurrent Lung Cancer: An In Vivo Animal Study.

Authors:  Peng Zhang; Bin Wang; Xiaoming Chen; Dusica Cvetkovic; Lili Chen; Jinyi Lang; C-M Ma
Journal:  Dose Response       Date:  2015-05-25       Impact factor: 2.658

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.